These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3371839)

  • 1. Pharmacokinetic interaction between nifedipine and propranolol.
    Zylber-Katz E; Turetz-Abramovitch M; Koren G; Levy M
    Fundam Clin Pharmacol; 1988; 2(1):29-35. PubMed ID: 3371839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.
    Bauer LA; Murray K; Horn JR; Opheim K; Olsen J
    Eur J Clin Pharmacol; 1989; 37(3):257-60. PubMed ID: 2612540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of the calcium antagonists nicardipine and nifedipine, and the calcium agonist BAY-K-8644, on the pharmacokinetics of propranolol in rats.
    Vercruysse I; Schoors DF; Massart DL; Dupont AG
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):721-6. PubMed ID: 7694636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine.
    Ndanusa BU; Mustapha A; Abdu-Aguye I
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1571-5. PubMed ID: 9226591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
    Levine MA; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1988 Jan; 43(1):39-48. PubMed ID: 2826066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetic interaction of propranolol and nifedipine in patients with angina of effort].
    Kukushkin SK; Rumiantsev DO; Belolipetskaia VG; Kokurina EV; Piotrovskiĭ VK; Metelitsa VI
    Eksp Klin Farmakol; 1994; 57(1):32-5. PubMed ID: 8142860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
    Hatorp V; Hansen KT; Thomsen MS
    J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers.
    Schoors DF; Vercruysse I; Musch G; Massart DL; Dupont AG
    Br J Clin Pharmacol; 1990 May; 29(5):497-501. PubMed ID: 2350528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Cheymol G; Poirier JM; Barre J; Pradalier A; Dry J
    J Clin Pharmacol; 1987 Nov; 27(11):874-9. PubMed ID: 3429695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
    Kiriyama A; Honbo A; Nishimura A; Shibata N; Iga K
    Regul Toxicol Pharmacol; 2016 Apr; 76():21-9. PubMed ID: 26773344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
    Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of interaction between lansoprazole and propranolol, a pharmacokinetic and safety assessment.
    Karol MD; Locke CS; Cavanaugh JH
    J Clin Pharmacol; 2000 Mar; 40(3):301-8. PubMed ID: 10709160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans.
    Qureshi S; Laganière S; Caillé G; Gossard D; Lacasse Y; McGilveray I
    Pharm Res; 1992 May; 9(5):683-6. PubMed ID: 1608903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.
    Boje KM; Fung HL
    J Pharmacol Exp Ther; 1989 May; 249(2):567-71. PubMed ID: 2724140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):378-87. PubMed ID: 27129011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etintidine-propranolol interaction study in humans.
    Huang SM; Weintraub HS; Marriott TB; Marinan B; Abels R
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):557-68. PubMed ID: 2897462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic and pharmacodynamic interaction between lacidipine and propranolol in healthy volunteers.
    Hall ST; Harding SM; Hassani H; Keene ON; Pellegatti M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S13-7. PubMed ID: 1725444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia.
    Barton JR; Prevost RR; Wilson DA; Whybrew WD; Sibai BM
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):951-4. PubMed ID: 1951561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.